| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
Eupraxia Pharmaceuticals Inc.
13D/A
EPRX · 29842P105
|
9.0% |
3/16/2026
Event 3/13/2026
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.